ERAS Labo (Grenoble, France) is a CDMO mostly active in the fields of nuclear medicine (radiochemistry) and oligotherapy for more than 30 years. ERAS Labo master all steps, from the development of complex multi-steps syntheses to the routine production of single dose vials filled in clean rooms. Its expertise in chemical synthesis and analytical chemistry is recognized by its customers, who appreciate the concentration of different skills into a small team.
Company Details
- Employees
- 21
- Founded
- -
- Address
- Saint-Nazaire-Les-Eymes
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- eras-labo.com
- HQ
- Saint-Nazaire-les-Eymes
Eras Labo Questions
Eras Labo's website is eras-labo.com
Eras Labo's LinkedIn profile is https://fr.linkedin.com/company/eras-labo
Eras Labo has
21 employees.
View email and phone details for 21
employees at Eras Labo.
Eras Labo's industry is
Pharmaceutical Manufacturing
Eras Labo's top competitors are
Jbt Hubup,
Pharmacos,
Carbogen Amcis,
Polypeptide Group,
Laboratoires Vivacy,
Trasis,
Bgene Genetics,
Elicityl,
Boiron France,
Euroapi.
Eras Labo's categories are Pharmaceutical Manufacturing
Eras Labo's founding year is 1991
